The immunohistochemical expression of FGFR1-4 was increased in the FGF9/PBS group and decreased in the groups treated with cordycepin whether the tumor was exposed to FGF9 or not (Figure 9A–E). This evidence concerns the gene FGF9 and neoplasm.